Literature DB >> 17399846

Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis.

Erik van Os1, Walter W van den Broek, Paul G H Mulder, Pieter C J ter Borg, Jan A Bruijn, Henk R van Buuren.   

Abstract

BACKGROUND/AIMS: Former studies reported a high prevalence of depression in patients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). These studies hypothesized that the presence of depression could explain the fatigue experienced by these patients.
METHODS: Our aim was to study the prevalence of depression in a Dutch population with PBC and PSC. In addition, to investigating the effects of using an additional diagnostic structured psychiatric interview, after screening with the Beck Depression Inventory (BDI), a self-report severity scale instrument used in former studies. Patients with PBC and PSC (n=92) completed the BDI. Patients with scores of 10 or higher (n=39) were interviewed using a structured psychiatric interview. Patients with scores lower than 10 were at random (30/53, 57%) also interviewed using a structured psychiatric interview.
RESULTS: Of the 92 patients that were included 42% had depressive symptoms according to the BDI. However, of these patients only 3.7% had a depressive syndrome according to the DSM-IV criteria as assessed with the structured psychiatric interview.
CONCLUSIONS: The prevalence of a depressive disorder in patients with PBC and PSC is not higher than in the general population. Fatigue in patients with PBC and PSC cannot be explained by depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17399846     DOI: 10.1016/j.jhep.2007.01.036

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  16 in total

Review 1.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

2.  Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study.

Authors:  Jiangyi Zhu; Yongquan Shi; Xinmin Zhou; Zengshan Li; Xiaofeng Huang; Zheyi Han; Jianhong Wang; Ruian Wang; Jie Ding; Kaichun Wu; Ying Han; Daiming Fan
Journal:  Front Med       Date:  2012-11-23       Impact factor: 4.592

3.  Efficient generation of biliary epithelial cells from rabbit intrahepatic bile duct by Y-27632 and Matrigel.

Authors:  Lifang Jin; Shaohui Ji; Aijing Sun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-14       Impact factor: 2.416

Review 4.  Primary biliary cirrhosis.

Authors:  Douglas L Nguyen; Brian D Juran; Konstantinos N Lazaridis
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-10       Impact factor: 3.043

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Refractory pruritus in primary biliary cirrhosis.

Authors:  Nuno Cercas Pinheiro; Rui Tato Marinho; Fernando Ramalho; José Velosa
Journal:  BMJ Case Rep       Date:  2013-11-14

Review 7.  The medical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-03-12

Review 8.  Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management.

Authors:  Artur Kośnik; Maciej Wójcicki
Journal:  Prz Gastroenterol       Date:  2022-03-18

Review 9.  Primary Sclerosing Cholangitis: Therapeutic Options and Surveillance Management.

Authors:  Aditi Kumar; Daniel Wheatley; Amar Puttanna
Journal:  Clin Med Insights Gastroenterol       Date:  2016-06-09

10.  The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.

Authors:  Abdel-Aziz Shaheen; Gilaad G Kaplan; Wagdi Almishri; Isabelle Vallerand; Alexandra D Frolkis; Scott Patten; Mark G Swain
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.